247 results
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
exercise price of $1.62 per share awarded under our 2021 Equity Incentive Plan, as amended (our “2021 Equity Incentive Plan”), our 2012 Equity Incentive … Plan, as amended (together with our 2021 Equity Incentive Plan, our “equity incentive plans”), or outside of our equity incentive plans pursuant
424B5
9r4pcr uieg07uf
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-10.1
j6r39mhsk1faakrnlc9
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
b6cs3tqoffyjx17q
13 Nov 23
Registration of securities for employees
4:19pm
S-8
peiutpi
13 Nov 23
Registration of securities for employees
4:19pm
S-8
EX-5.1
cxkn43
13 Nov 23
Registration of securities for employees
4:19pm
8-K
hdwr2ly
7 Sep 23
Departure of Directors or Certain Officers
5:01pm